IAI Accepts, published online ahead of print on 15 September 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mesquita, R. D.
Right arrow Articles by Silva-Neto, M. A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mesquita, R. D.
Right arrow Articles by Silva-Neto, M. A. C.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00683-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine

Rafael D. Mesquita, Alan Brito Carneiro, André Bafica, Felipe Gazos-Lopes, Christina M. Takiya, Thaís Souto-Padron, Danielle P. Vieira, Antônio Ferreira-Pereira, Igor C. Almeida, Rodrigo T. Figueiredo, Bárbara N. Porto, Marcelo T. Bozza, Aurélio Graça-Souza, Angela H. C. S. Lopes, Geórgia C. Atella, and Mário A. C. Silva-Neto*

From the Instituto de Bioquímica Médica, Instituto de Ciências Biomédicas, Departamento de Histologia e Embriologia, and Instituto de Microbiologia Professor Paulo de Góes at Universidade Federal do Rio de Janeiro, UFRJ, 21940-590, Rio de Janeiro, RJ, Brazil; Divisão de Imunologia, Departamento de Microbiologia e Parasitologia, Universidade Federal de Santa Catarina, 88040-900, Florianópolis, SC, Brasil; Department of Biological Sciences, The Border Biomedical Research Center, University of Texas at El Paso, El Paso, TX 79968, USA

* To whom correspondence should be addressed. Email: maneto{at}bioqmed.ufrj.br.


arrow
Abstract

Trypanosoma cruzi, the etiological agent of Chagas disease, is transmitted by bug feces deposited on human skin during a blood meal. However, parasite infection occurs through the wound produced by insect mouthparts. Saliva of the triatominae bug Rhodnius prolixus is a source of lysophosphatidylcholine (LPC). Here, we tested the role of both triatomine saliva and LPC on parasite transmission. We show that vector saliva is a powerful inducer of cell chemotaxis. A massive number of inflammatory cells were found at the sites where LPC or saliva was inoculated into the mouse skin. LPC is a known chemoattractant for monocytes but neutrophil recruitment induced by saliva is LPC-independent. Pre-incubation of peritoneal macrophages with saliva or LPC increased five-fold the association of T. cruzi with these cells. Moreover, saliva and LPC block nitric oxide production by T. cruzi-exposed macrophages. Injection of saliva or LPC into mouse skin in the presence of the parasite induces an up to six-fold increase in blood parasitemia. Together, our data suggest that triatominae saliva enhance T. cruzi transmission and some of its biological effects are attributed to LPC. This is a demonstration that a vector-derived lysophospholipid may act as an enhancing factor of Chagas disease.